# OCCL share price today (OCCL Ltd, NSE: OCCLLTD)

> OCCL share price today: ₹164.47 at the NSE close on 3 November 2026. OCCL (NSE: OCCLLTD) is worth ₹823 crore and trades at a P/E of 10.8. > OCCL Ltd's results are improving, while its P/E is near the low end of its own history over 1 year, higher than only 11% of past readings. OCCLLTD · Chemicals - Organic · data as of 3 November 2026. Page: https://www.sectoralpha.in/stocks/occl-ltd

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Price: ₹164.47
- P/E: 10.8× (lower than 89% of the last 1 year)
- Revenue (Jun 2026): ₹220 Cr (+78.9% on a year ago)
- Profit (Jun 2026): ₹40.0 Cr (+207.7% on a year ago)
- Operating margin: 28.0% (+7.0 points on a year ago)
- ROCE: 13%, FY26

Biggest thing to watch: the price has already been rising for 21 weeks, so timing is the risk more than the business. ## What is the OCCL share price today? OCCL Ltd's share price was ₹164.47 at the close on 3 November 2026. It has been rising for 21 weeks. That is 16.8% above its average price over the last 200 trading days. Over the past 13 weeks it has done better than the NIFTY 500, and it has stayed ahead for 23 weeks in a row. Since its first close in our records, on 17 April 2026, it has traded between ₹93 and ₹219, and at that close it sat 57% of the way up from that low. Over the last 6 months the share price moved +71% while the NIFTY 500 moved −5%, so it is ahead of the index over that whole period. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What changed at OCCL this quarter? Three changes stood out: best operating margin in 8 quarters, highest quarterly profit in 12 quarters and revenue up on a year earlier for 4 quarters in a row (every quarter we can compare). 1. Best operating margin in 8 quarters Operating margin was 28% in the June 2026 quarter, against 21% a year earlier. 2. Highest quarterly profit in 12 quarters Profit of ₹40 crore in the June 2026 quarter is the highest of the last 12 quarters. 3. Revenue up on a year earlier for 4 quarters in a row (every quarter we can compare) In the June 2026 quarter revenue was ₹220 crore, +78.9% on a year earlier. ## What are OCCL's latest quarterly results? For April to June 2026 (the quarter ended 30 June 2026), OCCL reported revenue of ₹220 crore, up 78.9% from ₹123 crore a year earlier, and a profit of ₹40.0 crore, up 207.7% from ₹13.0 crore. ### OCCL results: April to June 2026 against a year earlier

| Measure | April to June 2026 | April to June 2025 | Change |
| --- | --- | --- | --- |
| Revenue | ₹220 crore | ₹123 crore | +78.9% |
| Profit | ₹40.0 crore | ₹13.0 crore | +207.7% |
| Earnings per share | ₹8.06 | ₹2.63 | +206.5% |
| Operating margin | 28.0% | 21.0% | +7.0 points |

The next results, for July to September 2026, are due by 14 November 2026: listed companies must publish quarterly results within 45 days of the quarter's end (60 days for the January to March quarter). The newest call in our records is from 5 February 2026, about October to December 2025; a call about these results is not in our records yet. (From the company's reported quarterly results (quarter ended 30 June 2026). Revenue and profit in ₹ crore.)

## What is the OCCL share price history? OCCL closed at ₹164.47 on 3 November 2026. Its highest weekly close since April 2026 was ₹218.54 on 9 October 2026. ### OCCL share price: then and now

| When | Close | Change to 3 Nov 2026 |
| --- | --- | --- |
| 1 week ago · 23 Oct 2026 | ₹161.96 | +1.5% |
| 1 month ago · 1 Oct 2026 | ₹193.49 | −15.0% |
| 6 months ago · 30 Apr 2026 | ₹99.41 | +65.4% |
| Earliest weekly close in our records · 17 Apr 2026 | ₹96.32 | +70.8% |
| Highest weekly close since April 2026 · 9 Oct 2026 | ₹218.54 | −24.7% |
| Lowest weekly close since April 2026 · 15 May 2026 | ₹92.51 | +77.8% |

Weekly closing prices. Each change is the move from that price to the 3 Nov 2026 close. A day's intraday high or low can go beyond these weekly closes. (36 weekly closes from 17 April 2026 to 3 November 2026.)

## What is the latest news on OCCL? 3 Nov 2026: OCCL closed at ₹164.47, up 1.5% on the week and down 15.0% on the month. 20 Aug 2026: ex-date for a dividend of ₹1.80 a share. ### Earlier

- Results for April to June 2026: Revenue up 78.9% and profit up 207.7% on a year earlier. - 5 Feb 2026: OCCL held its results call for October to December 2025. - 7 Nov 2025: ex-date for an interim dividend of ₹1 a share. ## What dividend does OCCL pay? OCCL paid ₹2.80 a share in regular dividends in the 12 months to 4 November 2026 (2 payments), a yield of 1.70% at the ₹164.47 close on 3 November 2026. The last was a dividend of ₹1.80 a share, ex-date 20 August 2026. ### OCCL dividends since 1 April 2021

| Ex-date | Dividend per share | Type |
| --- | --- | --- |
| 20 Aug 2026 | ₹1.80 | Dividend |
| 7 Nov 2025 | ₹1 | Interim |
| 21 Jul 2025 | ₹1.50 | Dividend |

Amounts as the company declared them on the NSE. A dividend goes to whoever owns the shares before the ex-date. The record date is the same day as the ex-date for every payment here. 1 of 5 Of the last 5 financial years, years with an NSE dividend record

Yes. OCCL Ltd paid out 29% of its profit as dividends in FY26, and it paid a dividend in 2 of its last 4 reported years. (From the NSE corporate-actions record, read 4 November 2026.)

## What did OCCL management say on the latest results call? On the call for October to December 2025, held on 5 February 2026, OCCL's management spoke about the quarter; the main points are below. > “When the tariffs went from 0% to 50%, you can imagine that to maintain the same price, we had to give discounts in the American market in the range of 25%.”
> Akshit Goenka, Joint Managing Director, on the call for October to December 2025

Source: [the call transcript](https://files.tijoristack.ai/concall/transcript/58210-05-Feb-2026.pdf). (From the call for October to December 2025, 5 February 2026. The April to June 2026 results are out since, so this part may be out of date until we update it.)

## What could change the OCCL story? What are the risks? If sulphur stays above ₹50/unit for 3+ quarters, margin recovery thesis fails, management has already proven wrong on this call twice. ### The main risks

- Sulphur Cost Sustained Elevation: If sulphur stays above ₹50/unit for 3+ quarters, margin recovery thesis fails, management has already proven wrong on this call twice. ✓ fact
- Management Guidance Credibility: Four factual contradictions in three consecutive calls, no forward guidance should be taken at face value without independent verification. ✓ fact
- Supply Glut, 4-5 Year Structural Overhang: Global insoluble sulphur supply exceeds demand by 20%+; pricing power is structurally capped for 4-5 years at 2-3% demand growth. ✓ fact

(Our read after the latest results, written 14 June 2026.)

## Which stock lists is OCCL on? OCCL is on one of our India lists: Dividend stocks. [Dividend stocks Regular dividend yield (%): 1.71](https://www.sectoralpha.in/dividend-stocks-india)

## Is OCCL profitable? OCCL Ltd earned ₹40.0 Cr of net profit in the Jun 2026 quarter, +207.7% on the same quarter a year earlier. That is the 4th quarter in a row of profit growth. Full-year FY26 profit was ₹48.0 Cr. That is 18.2% of the quarter's revenue. The same quarter a year earlier earned ₹13.0 Cr. For the full year, FY26 profit was ₹48.0 Cr (+128.6% on the year before). Why profit moved: revenue changed +78.9% on a year earlier and the margin moved +7.0 percentage points. Most of the change came from keeping more of each sale. On average over the last four quarters, profit changed +92.8% and revenue +38.4%. Profit is growing faster than sales: fixed costs are spread over more sales, so each extra rupee of revenue adds more to profit. ## How much revenue does OCCL make, and is it growing? OCCL Ltd reported ₹220 Cr of revenue in the Jun 2026 quarter, +78.9% on the same quarter a year earlier. That is the 4th quarter in a row with growth on the year before. The last full year, FY26, came in at ₹506 Cr. The last four reported quarters add to ₹603 Cr. A growth rate over several years is not shown, because there are too few years of figures to work one out properly. FY26 revenue was ₹506 Cr, +64.8% on the year before. ## How much of every ₹100 of sales does OCCL keep? OCCL Ltd's operating margin was 28.0% in the Jun 2026 quarter, 7.0 percentage points higher than the same quarter a year ago. Why this happened. Sulphur averaged ₹29/unit in Jul-Sep 2025, spiked to ₹52/unit by Feb 2026, a 79% intra-quarter surge. Each ₹1/unit move = approximately ₹1 Cr/quarter PAT impact (100,000 MT annual volume). Management noted historically such spikes are unsustainable but the Nov 2025 call was proven wrong on timing. Normalization to ₹30-35/unit would recover approximately ₹17-22 Cr annualized PAT. Across 2 years it has been between 17.0% and 18.0%. Why the margin moved: operating margin changed +6.7 percentage points on the year while gross margin changed −3.3 points. So the gain came mostly from costs below the gross margin, such as staff and overheads, measured against sales. ## Is OCCL's profit turning into cash? Over the last 2 years, 117% of OCCL Ltd's reported profit came in as cash from its operations, so the profit is backed by cash. In FY26 it brought in ₹11.0 Cr of operating cash against ₹48.0 Cr of profit. After ₹12.0 Cr of spending on assets, free cash was −₹1.0 Cr: it spent more than its operations brought in. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. Why 117% of profit came in as cash: the cash cycle got 32 days shorter between FY25 and FY26, so cash that used to wait in the business now arrives sooner. What to look at next: the bigger use of cash is spending on new assets, at 8.3× depreciation over three years. The next section checks what that spending is building. ## Where does OCCL's cash go? OCCL Ltd's cash cycle, the days between paying suppliers and getting paid by customers, was 160 days in FY26, down from 192 days in FY25. It spent ₹415 Cr on assets over the last 3 years. Customers take 61 days to pay, and stock sits for 139 days on average. Why this happened. Current domestic market share 55-58%. Management aiming for 60-65% by aggressively capturing share following ADD imposition. Indian tyre industry growing faster than global 2-3% demand, management cited 7-8% India growth expected for FY26. The company operates at lowest global production cost comparable to Chinese players. At FY26 sales of ₹506 Cr, each day of that cycle ties up about ₹1.4 Cr, so roughly ₹222 Cr is tied up in the business at any time. FY26: customers took 61 days to pay and stock sat for 139 days, about 4.6 months of sales sitting as stock, for a full cycle of 160 days, shorter than FY25's 192. The full loop: cash goes out to suppliers and production on day 0. Stock sits for 139 days. Customers pay about 61 days after that. Suppliers are paid at 41 days. Together that makes the 160-day cycle. Spending on assets: ₹415 Cr over the last 3 years, against ₹50.0 Cr of depreciation (the yearly wear and tear on existing assets). So it is building well beyond replacing what wears out. Work still in progress is ₹2.0 Cr (FY26): assets paid for that are not earning yet. In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns. ## What is OCCL's P/E ratio, and how does it compare with its own history? OCCL Ltd's P/E is 10.8×, near the low end of its own history: it has been lower only 11% of the time. Its usual P/E (the middle reading) is 13.1×, over 1 year of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth. The P/E here, and its history, use a profit figure that can leave out one-off items, so it can differ from a P/E worked out on the quarterly results. Those results' earnings per share for the four quarters to Jun 2026 add up to ₹14.98. In short: the multiple is low against its own past, so the earnings trend underneath matters more than the multiple. ## What growth does the OCCL share price assume? Worked out from its price on 27 August 2026, OCCL Ltd's share price assumed profit growth of about 14.1% a year. Today its P/E is 10.8×, lower than 89% of its own last 1 year. This is a one-day reading, taken on 27 August 2026. Every other number on this page, the multiple included, uses the latest price as of 3 November 2026. A higher price assumes more growth and a lower price less, so it changes whenever the price changes, and this page does not update it between measurements. ## Is the OCCL business getting better or worse? OCCL Ltd's business trend cannot be read yet. There are fewer than eight usable quarters of growth figures, so there is not enough history to read the trend. This is based on 4 quarters of 1 measure, with some gaps. Why it matters: with too little history, we say so rather than guess a direction. The return figures here are yearly, not quarterly. They show level and direction only; they can support the growth lines but never decide the reading alone. There are fewer than eight usable quarters, so this page does not guess a direction from so little history. ## What is the OCCL story, and has it been checked? OCCL Ltd's story is not scored yet against the checks our research set on 14 June 2026. Where it sits in its own cycle: Not stated in the research file. Still open: If sulphur stays above ₹50/unit for 3+ quarters, margin recovery thesis fails, management has already proven wrong on this call twice. What is proven. See the research file

What is not proven yet. If sulphur stays above ₹50/unit for 3+ quarters, margin recovery thesis fails, management has already proven wrong on this call twice. What the surface reading misses. The surface reading is: Input cost spike → margin compression → poor operating leverage The research reads it further: Sulphur is cyclically volatile, this is an exogenous commodity spike unrelated to OCCL's competitive position or structural margin deterioration. Sulphuric acid byproduct provides a partial natural hedge (priced at sulphur-plus). What the surface reading misses. A 25th percentile on 4 data points is statistically meaningless. EPS has been rising (500% over 8Q) but is distorted by one-off tax items. Sources: our stock research file (14 June 2026) · quarterly results through Jun 2026 · the company’s own earnings calls. The story check is re-scored every results season; the record below never changes. ## Did OCCL management deliver what it promised? What OCCL Ltd's management promised, against what actually happened: 4 promises on the record. Read straight from the company’s own earnings calls. A promise that slipped stays on this page after it is met. US Export Operations Contradiction · 5 February 2026. In the November 2025 call, management explicitly stated they had reached an arrangement to continue supplying into the US market despite the new tariffs. However, in the February 2026 call, they retrospectively stated that exports to the market were "suspended" due to the tariff, directly contradicting the prior claim of continuity. Earlier call (Nov 2025): “We have come into an arrangement where we continue to sell our products to the US. We are hopeful... this should come to a resolution soon.” Later call (Feb 2026): “Our strategy with the export market continues as before. It was suspended because of the tariff, but now that the tariffs have been rolled back, we are looking at the export market with renewed vigor.”

Competitor Pricing Power Reversal · 5 February 2026. By the February 2026 call, management admitted that the benefit of the ADD had been effectively "taken away" because prices did not increase as expected, contradicting the specific competitive assessment made earlier. Later call (Feb 2026): “The fact that the tariff did not increase the price... means they have taken away the benefit of the anti-dumping duty.”

Sulphur Price Guidance Failure · 5 February 2026. Management guided in the November 2025 call that high sulphur prices were unsustainable and expected them to decline post-Q3 to benefit margins. In the February 2026 call, they reported that sulphur prices had actually nearly doubled (from Rs. 29 to Rs. 52) during that exact period, indicating a material failure in their input cost forecasting. Earlier call (Nov 2025): “Normally, if we look at it historically, these types of high sulphur prices are not sustainable. There has been a substantial increase in sulfur prices.”

EBITDA Margin Guidance Retraction · 3 November 2025. Management expressed strong confidence in the July 2025 call that the then-current EBITDA margin of 21.7% was sustainable for the fiscal year. Following a sharp drop to 16.8% in the next quarter, they fully reversed this guidance in the November 2025 call, stating it is now 'very difficult' to answer questions on margins. Earlier call (Jul 2025): “Again, we feel that this is something, at least for this year, we should be having... I would say that this is a good guidance to begin with, our quarter and that is the only guidance I can give as of now.” Later call (Nov 2025): “The problem is, you know, very difficult to answer this question. Uh, you know, considering the very fluid geopolitical and geo-economical situation that we are in.”

Every quote above is taken word for word from the company’s own earnings calls. ## How much does OCCL earn on its capital? OCCL Ltd earned a ROCE of 13% in FY26. That is up from a low of −86% in FY24. We cannot compare its return on capital used with its cost of capital from the data we have. It comes from a 9.5% net margin and 0.84× asset turnover (sales divided by assets). Why the return is what it is (FY26): a 9.5% net margin × 0.84× asset turnover × 1.40× leverage (assets divided by equity) ≈ 11.2% on equity. The margin does its share; borrowing plays a small part, so this return is earned, not borrowed. ## Does OCCL have too much debt? OCCL Ltd had ₹90.0 Cr of borrowings against ₹431 Cr of equity in FY26, so its debt is 0.21× its equity. Its operating profit is 18 times its interest bill. Over 3 years borrowings went from ₹0.0 Cr to ₹90.0 Cr. Over the last 3 of those years it spent ₹415 Cr on assets. Part of the spending on assets is being paid for with borrowed money. ## What is the OCCL shareholding pattern? No group of OCCL Ltd's owners changed its stake by a full percentage point over the last two years. Foreign institutions moved −0.8 points over the same period, to 0.2%. This uses the four owner groups that companies report every quarter; nothing is guessed between filings. Over the last two years: Domestic institutions: −0.9 points over 7 quarters, to 4.8%; Foreign institutions: −0.8 points over 7 quarters, to 0.2%; Promoters: +0.0 points over 7 quarters, to 51.8%. ## How far is OCCL from balance-sheet trouble? For OCCL Ltd, the Z-score is not available, so we say so rather than guess one. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. The debt, cash-flow and return sections show the balance-sheet figures we do have, each with its own date. ## How does OCCL rank in its industry? 59.1 out of 100, rank 4 of 20 in Chemicals - Organic, with 56% of the evidence available. OCCL Ltd scores 59.1 out of 100 against the 20 companies it is compared with in Chemicals - Organic, ranking 4. Some evidence is missing, so the score is pulled toward the middle on purpose. The four parts add up to the total exactly: 23.6 + 12.3 + 11.1 + 12.1 = 59.1. This is the same number shown on the industry page; it is worked out once for the whole group and read here. What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector. ## Which companies is OCCL compared with? OCCL ranks 4 of 20 Chemicals - Organic companies on the 4-Factor Sector Score, with 59.1 out of 100. 1. [Nitta Gelatin India Ltd](https://www.sectoralpha.in/stocks/nitta-gelatin-india-ltd) NITTAGELA · quiet · Most evidence points up · 85% evidence 76.9 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 30.4/35 · Revenue 15% · Profit 49.4% · Operating margin change 9 points · 100% evidence Capital efficiency 21.3/25 · ROCE 27.7% · Operating margin 28% · 100% evidence Valuation 13.2/20 · P/E 12.1× · PEG 0.95 · 100% evidence Relative strength 12.0/20 · Lead over its industry n/a · Lead over NIFTY 500 35.5% · 1 year n/a · 25% evidence · 5 of 12 weeks ahead Exact sum: 30.4 + 21.3 + 13.2 + 12 = 76.9 · What this means: Earnings, capital efficiency and relative strength all agree. The open questions are about management, upcoming events and risks. 2. [Indo Amines Ltd](https://www.sectoralpha.in/stocks/indo-amines-ltd) INDOAMIN · losing its lead · Most evidence points up · 81% evidence 66.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 20.8/35 · Revenue 13.3% · Profit 24.2% · Operating margin change 3 points · 88% evidence Capital efficiency 16.8/25 · ROCE 18.9% · Operating margin 14% · 100% evidence Valuation 19.0/20 · P/E 10.6× · PEG 0.32 · 100% evidence Relative strength 9.5/20 · Lead over its industry n/a · Lead over NIFTY 500 2.3% · 1 year -10.4% · 25% evidence · 4 of 12 weeks ahead Exact sum: 20.8 + 16.8 + 19 + 9.5 = 66.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 3. [Valiant Organics Ltd](https://www.sectoralpha.in/stocks/valiant-organics-ltd) VALIANTORG · breaking out · Evidence leans up · 78% evidence 61.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 21.4/35 · Revenue 1.5% · Profit 100% · Operating margin change 6 points · 83% evidence Capital efficiency 9.0/25 · ROCE 5.5% · Operating margin 18% · 76% evidence Valuation 10.9/20 · P/E 23.2× · PEG n/a · 50% evidence Relative strength 19.8/20 · Lead over its industry 24.1% · Lead over NIFTY 500 48.6% · 1 year 39.6% · 100% evidence · 10 of 12 weeks ahead Exact sum: 21.4 + 9 + 10.9 + 19.8 = 61.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 4. OCCL Ltd this page OCCLLTD · breaking out · Too little evidence to rank firmly · 56% evidence 59.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.6/35 · Revenue 40.6% · Profit 100% · Operating margin change 7 points · 83% evidence Capital efficiency 12.3/25 · ROCE 13% · Operating margin 28% · 76% evidence Valuation 11.1/20 · P/E 11× · PEG n/a · 15% evidence Relative strength 12.1/20 · Lead over its industry n/a · Lead over NIFTY 500 45.3% · 1 year n/a · 25% evidence · 12 of 12 weeks ahead Exact sum: 23.6 + 12.3 + 11.1 + 12.1 = 59.1 · What this means: Some evidence is missing, so the score is pulled toward the middle on purpose. 5. [BASF India Ltd](https://www.sectoralpha.in/stocks/basf-india-ltd) BASF · quiet · Evidence leans up · 71% evidence 57.3 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.8/35 · Revenue 6.5% · Profit 62.4% · Operating margin change 4 points · 88% evidence Capital efficiency 11.7/25 · ROCE 14.5% · Operating margin 10% · 100% evidence Valuation 14.1/20 · P/E 21.4× · PEG n/a · 50% evidence Relative strength 7.7/20 · Lead over its industry n/a · Lead over NIFTY 500 -13% · 1 year -30.9% · 25% evidence · 5 of 12 weeks ahead Exact sum: 23.8 + 11.7 + 14.1 + 7.7 = 57.3 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 6. [Elantas Beck India Ltd](https://www.sectoralpha.in/stocks/elantas-beck-india-ltd) ELANTAS · leader · Evidence leans up · 67% evidence 57.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 20.7/35 · Revenue 18.7% · Profit 35.5% · Operating margin change 1 points · 95% evidence Capital efficiency 18.1/25 · ROCE 21.2% · Operating margin 23% · 76% evidence Valuation 6.5/20 · P/E 54.1× · PEG n/a · 50% evidence Relative strength 11.8/20 · Lead over its industry n/a · Lead over NIFTY 500 31.9% · 1 year 33.1% · 25% evidence · 12 of 12 weeks ahead Exact sum: 20.7 + 18.1 + 6.5 + 11.8 = 57.1 · What this means: A strong business with a high valuation: it would need rising earnings, or a lower multiple, to score better on value. 7. [Fine Organic Industries Ltd](https://www.sectoralpha.in/stocks/fine-organic-industries-ltd) FINEORG · leader · Evidence leans up · 96% evidence 56.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 13.9/35 · Revenue 7.1% · Profit 5.8% · Operating margin change 4 points · 88% evidence Capital efficiency 17.8/25 · ROCE 21.5% · Operating margin 25% · 100% evidence Valuation 15.0/20 · P/E 35.3× · PEG 0.58 · 100% evidence Relative strength 9.9/20 · Lead over its industry -7.6% · Lead over NIFTY 500 12.4% · 1 year 13.8% · 100% evidence · 9 of 12 weeks ahead Exact sum: 13.9 + 17.8 + 15 + 9.9 = 56.6 · What this means: The valuation scores well, but earnings are not improving yet, so the business does not back up the low multiple so far. 8. [Laxmi Organic Industries Ltd](https://www.sectoralpha.in/stocks/laxmi-organic-industries-ltd) LXCHEM · quiet · Evidence leans up · 81% evidence 54.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 21.1/35 · Revenue 5.5% · Profit 26% · Operating margin change 7.6 points · 88% evidence Capital efficiency 10.8/25 · ROCE 4.7% · Operating margin 12% · 100% evidence Valuation 13.1/20 · P/E 33.8× · PEG 1.14 · 100% evidence Relative strength 9.2/20 · Lead over its industry n/a · Lead over NIFTY 500 1.8% · 1 year -22% · 25% evidence · 10 of 12 weeks ahead Exact sum: 21.1 + 10.8 + 13.1 + 9.2 = 54.2 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 9. [Balaji Amines Ltd](https://www.sectoralpha.in/stocks/balaji-amines-ltd) BALAMINES · quiet · Evidence leans up · 78% evidence 53.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.2/35 · Revenue 11.1% · Profit 41.6% · Operating margin change 10 points · 83% evidence Capital efficiency 13.1/25 · ROCE 11% · Operating margin 25% · 76% evidence Valuation 9.1/20 · P/E 28× · PEG n/a · 50% evidence Relative strength 8.2/20 · Lead over its industry -2.5% · Lead over NIFTY 500 15.2% · 1 year 25.3% · 100% evidence · 6 of 12 weeks ahead Exact sum: 23.2 + 13.1 + 9.1 + 8.2 = 53.6 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 10. [Fairchem Organics Ltd](https://www.sectoralpha.in/stocks/fairchem-organics-ltd) FAIRCHEMOR · quiet · Evidence leans up · 100% evidence 53.3 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 30.3/35 · Revenue 17.1% · Profit 100% · Operating margin change 6.2 points · 100% evidence Capital efficiency 7.0/25 · ROCE 3.3% · Operating margin 10% · 100% evidence Valuation 13.0/20 · P/E 32.7× · PEG 0.84 · 100% evidence Relative strength 3.0/20 · Lead over its industry -15.4% · Lead over NIFTY 500 3.2% · 1 year -15.9% · 100% evidence · 9 of 12 weeks ahead Exact sum: 30.3 + 7 + 13 + 3 = 53.3 · What this means: Earnings are strong; relative strength in its sector is -15.4% and the one-year return is -15.9%. 11. [Sigachi Industries Ltd](https://www.sectoralpha.in/stocks/sigachi-industries-ltd) SIGACHI · breaking out · Evidence leans down · 100% evidence 49.4 out of 100 Growth Capital Valuation Relative
12. [GFL Ltd](https://www.sectoralpha.in/stocks/gfl-ltd) GFLLIMITED · breaking out · Evidence leans down · 71% evidence 48.6 out of 100 Growth Capital Valuation Relative
13. [Jyoti Resins and Adhesives Ltd](https://www.sectoralpha.in/stocks/jyoti-resins-and-adhesives-ltd) JYOTIRES · basing · Evidence leans down · 74% evidence 43.7 out of 100 Growth Capital Valuation Relative
14. [Foseco India Ltd](https://www.sectoralpha.in/stocks/foseco-india-ltd) FOSECOIND · leader · Evidence leans down · 81% evidence 41.1 out of 100 Growth Capital Valuation Relative
15. [Shree Ganesh Remedies Ltd](https://www.sectoralpha.in/stocks/shree-ganesh-remedies-ltd) SGRL · breaking out · Evidence leans down · 85% evidence 40.3 out of 100 Growth Capital Valuation Relative
16. [Oriental Aromatics Ltd](https://www.sectoralpha.in/stocks/oriental-aromatics-ltd) OAL · leader · Evidence leans down · 74% evidence 36.5 out of 100 Growth Capital Valuation Relative
17. [Gem Aromatics Ltd](https://www.sectoralpha.in/stocks/gem-aromatics-ltd) GEMAROMA · quiet · Too little evidence to rank firmly · 51% evidence 32.2 out of 100 Growth Capital Valuation Relative
18. [Sacheerome Ltd](https://www.sectoralpha.in/stocks/sacheerome-ltd) SACHEEROME · losing its lead · Too little evidence to rank firmly · 36% evidence 58.1 out of 100 Growth Capital Valuation Relative
19. [Shri Ahimsa Naturals Ltd](https://www.sectoralpha.in/stocks/shri-ahimsa-naturals-ltd) SHRIAHIMSA · leader · Too little evidence to rank firmly · 47% evidence 56.8 out of 100 Growth Capital Valuation Relative
20. [Citurgia Biochemicals Ltd](https://www.sectoralpha.in/stocks/citurgia-biochemicals-ltd) CITURGIA · Too little evidence to rank firmly · 25% evidence 34.3 out of 100 Growth Capital Valuation Relative

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led NIFTY 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read. The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section. Related companies: [Chemicals - Organic](https://www.sectoralpha.in/sectors/chemicals-organic), all 20 compared on one page. ## Which companies are close to OCCL in size? OCCL is the 16th largest of 20 Chemicals - Organic companies on Sector Alpha by market value (scores of 30 October 2026). Just above it: Sacheerome, Indo Amines and Valiant Organics. Just below it: Fairchem Organics, Shree Ganesh Remedies and Gem Aromatics. ### Chemicals - Organic companies close in size

1. [Sacheerome Ltd](https://www.sectoralpha.in/stocks/sacheerome-ltd) ₹922 crore
2. [Indo Amines Ltd](https://www.sectoralpha.in/stocks/indo-amines-ltd) ₹865 crore
3. [Valiant Organics Ltd](https://www.sectoralpha.in/stocks/valiant-organics-ltd) ₹864 crore
4. OCCL Ltd ₹841 crore
5. [Fairchem Organics Ltd](https://www.sectoralpha.in/stocks/fairchem-organics-ltd) ₹801 crore
6. [Shree Ganesh Remedies Ltd](https://www.sectoralpha.in/stocks/shree-ganesh-remedies-ltd) ₹792 crore
7. [Gem Aromatics Ltd](https://www.sectoralpha.in/stocks/gem-aromatics-ltd) ₹716 crore

[All 20 Chemicals - Organic companies, largest first](https://www.sectoralpha.in/sectors/chemicals-organic#all-companies)

### Companies close in size in other industries

1. [SJ Corporation Ltd](https://www.sectoralpha.in/stocks/sj-corporation-ltd) ₹845 crore · Diamond, Gems & Jewellery
2. [RSWM Ltd](https://www.sectoralpha.in/stocks/rswm-ltd) ₹843 crore · Textiles - Spinning
3. OCCL Ltd ₹841 crore
4. [Uni Abex Alloy Products Ltd](https://www.sectoralpha.in/stocks/uni-abex-alloy-products-ltd) ₹841 crore · Castings, Forgings & Fastners
5. [RNIT AI Solutions Ltd](https://www.sectoralpha.in/stocks/rnit-ai-solutions-ltd) ₹839 crore · IT - Software

## What else do people ask about OCCL? ### What is OCCL's share price today? OCCL Ltd's share price is ₹164.47. The whole company is worth ₹823 Cr on the market. In the last 52 weeks it traded between ₹93 to ₹219; today it is 57% of the way up from the low, 16.8% above its 200-day average. The price has been rising for 21 weeks (as of 3 November 2026). ### What were OCCL's latest quarterly results? OCCL Ltd reported revenue of ₹220 Cr and net profit of ₹40.0 Cr for the Jun 2026 quarter. Revenue rose 78.9% and profit rose 207.7% compared with a year earlier. Earnings per share were ₹8.06. The operating margin was 28.0%, 7.0 percentage points higher than a year earlier (as of 3 November 2026). ### What is OCCL's market cap? OCCL Ltd's market capitalisation is ₹823 Cr at a share price of ₹164.47. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 3 November 2026). ### How is OCCL performing? OCCL Ltd's share price has been rising for 21 weeks. In its latest quarter, revenue rose 78.9% and profit rose 207.7% compared with a year earlier. Over the past 13 weeks it has done better than the NIFTY 500, for 23 weeks running (as of 3 November 2026). ### Will OCCL's share price go up? This page does not forecast OCCL Ltd's share price. What it shows instead: the share price is ₹164.47, and it has been rising for 21 weeks. Its P/E of 10.8× is higher than 11% of its own last 1 years (as of 3 November 2026). ### Who owns OCCL? Promoters own 51.8% of OCCL Ltd, foreign institutions 0.2%, domestic institutions 4.8% and the public 43.3% (latest quarter). No group of owners changed its stake by a full point over the last two years (as of 3 November 2026). ### Where is OCCL in its business cycle? OCCL Ltd's FY26 operating margin was 18.0%, against a 2-year range of 17.0% to 18.0%: the middle of its own range, neither a peak nor a low. The latest quarter was 28.0%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 3 November 2026). ### What could break the OCCL story? Biggest thing to watch: the price has already been rising for 21 weeks, so timing is the risk more than the business. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 3 November 2026). ### Is OCCL a stock worth studying right now? What the numbers show: OCCL Ltd's results are improving, while its P/E is near the low end of its own history over 1 year, higher than only 11% of past readings. The main open question: the next one or two quarters of results. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 3 November 2026). ### Is there a OCCL share price forecast for 2026? What would change the story: If sulphur stays above ₹50/unit for 3+ quarters, margin recovery thesis fails, management has already proven wrong on this call twice. ## Lists

- Dividend stocks: https://www.sectoralpha.in/dividend-stocks-india

This is research, not advice. We’re not SEBI-registered.